(Q43109248)

14 November 2017

title

Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis (English)

1 reference

14 November 2017

0 references

1 reference

1 reference

7

1 reference

14 November 2017

Yun Hu

1

1 reference

14 November 2017

Guoyu Tong

2

1 reference

14 November 2017

Wei Xu

3

1 reference

14 November 2017

Jiajia Pan

4

1 reference

14 November 2017

Kathy Ryan

5

1 reference

14 November 2017

Rongze Yang

6

1 reference

14 November 2017

Da-Wei Gong

8

1 reference

14 November 2017

Dalong Zhu

9

1 reference

14 November 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Diabetes and Vascular Disease Research

14 November 2017

published in

1 reference

14 November 2017

volume

6

1 reference

14 November 2017

issue

4

1 reference

14 November 2017

page(s)

262-268

1 reference

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Statins as potent antiinflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Secondary prevention of cardiovascular disease in type 2 diabetes and prediabetes: a cardiologist's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Targeting cardiovascular risk in patients with diabetes: management of dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Early-onset carotid atherosclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

SAA, an apoprotein of HDL: its structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

High-density lipoproteins in sepsis and septic shock: metabolism, actions, and therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

The effects of statin therapy on plasma markers of inflammation in patients without vascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164109339966

21 January 2018

Identifiers

DOI

10.1177/1479164109339966

1 reference

14 November 2017

1 reference